Iris Acquisition Corp - Ordinary Shares - Class A (IRAA) News, Articles, Events & Latest Updates

Iris Acquisition (NASDAQ:IRAA) Trading Up 2.3%Zolmax • about 1 month ago

Shares of Iris Acquisition Corp (NASDAQ:IRAA Get Free Report) were up 2.3% during mid-day trading on Tuesday . The stock traded as high as $10.60 and last traded at $10.60. Approximately 781...

Share to Feed

IRAA Makes Notable Cross Below Critical Moving AverageMarket News Video • 9 months ago

In trading on Friday, shares of Iris Acquisition Corp - Class A (IRAA) crossed below their 200 day moving average of 9.85, changing hands as low as 9.82 per share. Iris Acquisition Corp - Class A shares are currently trading down about 1.1% on the day...

Program CD47, provided the CMC service by GenScript ProBio to InnobationBio, will further be advanced by the joint venture between Liminatus Pharma LLC and Iris Acquisition CorpPR Newswire • 10 months ago

Program CD47, provided the CMC service by GenScript ProBio to InnobationBio, will further be advanced by the joint venture between Liminatus Pharma LLC and Iris Acquisition Corp Program CD47, provided the CMC service by GenScript ProBio to InnobationBio, will further be advanced by the joint...

Iris Acquisition to combine with Liminatus PharmaSeeking Alpha - Healthcare • 10 months ago

Liminatus Pharma LLC and Iris Acquisition Corp to combine to incorporate and accelerate much-needed cancer treatmentsBusiness Wire • 10 months ago

Liminatus Pharma LLC (Liminatus), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies and Iris Acquisition Corp (Iris) (Nasdaq: IRAA), a publicly traded special purpose acquisition company (SPAC) formed for the purpose of acquiring or merging with one or...

52-Wk High	$0.00
52-Wk Low	$0.00

IRAA Iris Acquisition Corp - Ordinary Shares - Class A

About

Feed

News

Fundamentals

Latest IRAA News